Validation of a brief screen for cognitive impairment (BSCI) administered by telephone for use in the Medicare population

Disease Management

Volumn 8, Issue 4, 2005, Pages 223-234

  Hill, Jerrold ^a   McVay, Janine M ^b   Walter Ginzburg, Adrian ^a,c   Mills, Charles S ^d   Lewis, Janice ^e   Lewis, Barbara E ^f   Fillit, Howard ^a  

^a Alzheimers Drug Discovery Foundation   (United States)

^b Focus Managed Research Inc

^c TEL AVIV UNIVERSITY   (Israel)

^d Geriatrix of Massachusetts   (United States)

^e Fallon Clinic   (United States)

^f ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MINI MENTAL STATE EXAMINATION; PSYCHOMETRY; QUESTIONNAIRE; RECALL; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TELEPHONE; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; INTERVIEWS; MALE; MASS SCREENING; MEDICARE; PSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 24944585690     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2005.8.223     Document Type: Article

References (68)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the U.S. population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122.
2. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004;52:195-204.
3. Jost BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study. J Am Geriatr Soc 1995;43:1248-1255.
4. Larson EB, Kukull WA, Katzman RL. Cognitive impairment: dementia and Alzheimer's disease. Annu Rev Public Health 1992;13:431-449.
5. Ernst RL, Hay JW. The U.S. economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-1264.
6. Bloom BS, de Pouvourville N, Straus WL. Cost of illness of Alzheimer's disease: how useful are current estimates? Gerontologist 2003;43:158-164.
7. Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fam Med 2002;34:528-535.
8. Weiner M, Powe NR, Weller WE, Shaffer TJ, Anderson GF. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc 1998;46:762-770.
9. Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Am J Manag Care 2001;7: 809-818.
10. Richards KM, Shepherd MD, Crismon ML, Snyder EH, Jermain DM. Medical services utilization and charge comparisons between elderly patients with and without Alzheimer's disease in a managed care organization. Clin Ther 2000;22:775-791.
11. Murman DL. The costs of caring: medical costs of Alzheimer's disease and the managed care environment. J Geriatr Psychiatry Neurol 2001;14:168-178.
12. Gutterman EM, Markowitz J, Lewis B, Fillit HM. Cost of Alzheimer's disease and related dementia in managed-Medicare. J Am Geriatr Soc 1999;47:1065-1071.
13. Valcour VG, Masaki KH, Curb JD, Blanchette PL. The detection of dementia in the primary care setting. Arch Intern Med 2000;160:2964-2968.
14. Brummel-Smith KV. Alzheimer's disease and managed care: how much will it cost? J Am Geriatr Soc 1998;46:780-781.
15. Beier M, Blanchette P, Fillit H. Economic impact of the treatment of Alzheimer's disease. Oxford: Oxford Institute for Continuing Education, 2002.
16. Sloan FA, Taylor DH Jr. Effect of Alzheimer disease on the cost of treating other diseases. Alzheimer Dis Assoc Disord 2002;16:137-143.
17. Wimo A, Winblad B, Aguero-Torres H, von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003;17:63-67.
18. Centers for Medicare and Medicaid Services. Medicare program: voluntary chronic care improvement under traditional fee-for-service Medicare. Federal Register 2004;69:22065-22079.
19. Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology 2002;58:62-70.
20. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21. Knopman DS, Knudson D, Yoes ME, Weiss DJ. Development and standardization of a new telephonic cognitive screening test: the Minnesota Cognitive Acuity Screen (MCAS). Neuropsychiatry Neuropsychol Behav Neurol 2000;13:286-296.
22. Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care 2002;40:771-781.
23. Gatz M, Reynolds C, Nikolic J, Lowe B, Karel M, Pedersen N. An empirical test of telephone screening to identify potential dementia cases. Int Psychogeriatr 1995;7:429-438.
24. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive "vital signs" measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000;15:1021-1027.
25. Dubois B, Touchon J, Portet F, Ousset PJ, Vellas B, Michel B. "The 5 words": a simple and sensitive test for the diagnosis of Alzheimer's disease. Presse Med 2002;31:1696-1699.
26. Herlitz A, Hill RD, Fratiglioni L, Backman L. Episodic memory and visuospatial ability in detecting and staging dementia in a community-based sample of very old adults. J Gerontol A Biol Sci Med Sci 1995;50:M107-M113.
27. Chodosh J, Reuben DB, Albert MS, Seeman TE. Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 2002;50: 1051-1060.
28. Fillenbaum GG, Wilkinson WE, Welsh KA, Mohs RC. Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data. Arch Neurol 1994;51:916-921.
29. Gfeller JD, Horn GJ. The East Boston Memory Test: a clinical screening measure for memory impairment in the elderly. J Clin Psychol 1996;52:191-196.
30. Buckwalter JG, Crooks VC, Petitti DB. A preliminary psychometric analysis of a computer-assisted admin-istration of the Telephone Interview of Cognitive Status-modified. J Clin Exp Neuropsychol 2002;24:168-175.
31. Roccaforte WH, Burke WJ, Bayer BL. Validation of a telephonic version of the mini-mental state examination. J Am Geriatr Soc 1992;40:697-702.
32. Brandt J, Spender M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-117.
33. Metitieri T, Geroldi C, Pezzini A, Frisoni GB, Bianchetti A, Trabucchi M. The Itel-MMSE: an Italian telephone version of the Mini-Mental State Examination. Int J Geriatr Psychiatry 2001;16:166-167.
34. Mangione CM, Seddon JM, Cook EF, et al. Correlates of cognitive function scores in elderly outpatients. J Am Geriatr Soc 1993;41:491-497.
35. Lanska DJ, Schmitt FA, Stewart JM, Howe JN. Telephone-assessed mental state. Dementia 1993;4:117-119.
36. Jarvenpaa T, Rinne JO, Raiha I, et al. Characteristics of two telephone screens for cognitive impairment. Dement Geriatr Cogn Disord 2002;13:149-155.
37. Go RC, Duke LW, Harrell LE, et al. Development and validation of a Structured Telephone Interview for Dementia Assessment (STIDA): the NIMH Genetics Initiative. J Geriatr Psychiatry Neurol 1997;10:161-167.
38. Gatz M, Reynolds CA, John R, Johansson B, Mortimer JA, Pedersen NL. Telephone screening to identify potential dementia cases in a population-based sample of older adults. Int Psychogeriatr 2002;14:273-289.
39. Ferrucci L, Del LI, Guralnik JM, et al. Is the telephone interview for cognitive status a valid alternative in persons who cannot be evaluated by the Mini Mental State Examination? Aging (Milano) 1998;10:332-338.
40. Kawas C, Segal J, Stewart WF, Corrada M, Thai LJ. A validation study of the Dementia Questionnaire. Arch Neurol 1994;51:901-906.
41. Roccaforte WH, Burke WJ, Bayer BL, Wengel SP. Reliability and validity of the Short Portable Mental Status Questionnaire administered by telephone. J Geriatr Psychiatry Neurol 1994;7:33-38.
42. Fillit H, Mohs RC, Edelman LB, et al. A brief telephonic instrument to screen for cognitive impairment in a managed care population. J Clin Outcomes Management 2003;8:419-429.
43. Monteiro IM, Boksay I, Auer SR, Torossian C, Sinaiko E, Reisberg B. Reliability of routine clinical instruments for the assessment of Alzheimer's disease administered by telephone. J Geriatr Psychiatry Neurol 1998;11:18-24.
44. Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 2002;50:530-534.
45. Brooke P, Bullock R. Validation of a 6-item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry 1999;14:936-940.
46. Cossa FM, Sala SD, Musicco M, Spinnler H, Ubezio MC. The Milan overall dementia assessment and the mini-mental state examination compared: an epidemiological investigation of dementia. Eur J Neurol 1999;6:289-294.
47. Ellis RJ, Jan K, Kawas C, et al. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol 1998;55:360-365.
48. Froehlich TE, Robison JT, Inouye SK. Screening for dementia in the outpatient setting: the time and change test. J Am Geriatr Soc 1998;46:1506-1511.
49. Jacqmin-Gadda H, Fabrigoule C, Commenges D, Letenneur L, Dartigues JF. A cognitive screening battery for dementia in the elderly. J Clin Epidemiol 2000;53:980-987.
50. Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry 2002;47:723-733.
51. Robert PH, Schuck S, Dubois B, et al. Screening for Alzheimer's disease with the short cognitive evaluation battery. Dement Geriatr Cogn Disord 2003;15:92-98.
52. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000;15:548-561.
53. Solomon PR, Hirschoff A, Kelly B, et al. A 7-minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol 1998;55:349-355.
54. Barberger-Gateau P, Dartigues JF, Letenneur L. Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia. Age Ageing 1993;22:457-463.
55. Small GW. Treatment of Alzheimer's disease: current approaches and promising developments. Am J Med 1998;104:32S-38S.
56. Dwolatzky T, Whitehead V, Doniger GM, et al. Validity of a novel computerized cognitive battery for mild cognitive impairment. BioMed Geriatr 2003;3.
57. Cromwell DA, Eagar K, Poulos RG. The performance of instrumental activities of daily living scale in screening for cognitive impairment in elderly community residents. J Clin Epidemiol 2003;56:131-137.
58. Green CR, Mohs RC, Schmeidler J, Aryan M, Davis KL. Functional decline in Alzheimer's disease: a longitudinal study. J Am Geriatr Soc 1993;61.
59. Njegovan V, Hing MM, Mitchell SL, Molnar FJ. The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol A Biol Sci Med Sci 2001;56:M638-M643.
60. Zanetti O, Frisoni GB, Rozzini L, Bianchetti A, Trabucchi M. Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. Age Ageing 1998;27:615-622.
61. Mohs RC, Cohen L. Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacol Bull 1988;24:627-628.
62. Davis PB, Morris JC, Grant E. Brief screening tests versus clinical staging in senile dementia of the Alzheimer type. J Am Geriatr Soc 1990;38:129-135.
63. SPSS Inc. SPSS advanced statistics 7.5. Chicago: SPSS Inc., 1997.
64. Carpenter B, Dave J. Disclosing a dementia diagnosis: a review of opinion and practice, and a proposed research agenda. Gerontologist 2004;44:149-158.
65. Marin D, Amaya K, Casciano R, et al. Impact of rivastigmine on costs and on time spent in caregiving for families of patients with Alzheimer's disease. Int Psychogeriatr 2003;15:385-398.
66. Chang CY, Silverman DH. Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease. Expert Rev Mol Diagn 2004;4: 63-69.
67. Bynum JPW, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The relationship between a dementia diagnosis, chronic illness, Medicare expenditures, and hospital use. J Am Geriatr Soc 2004;52: 187-194.
68. Scanlan J, Borson S. The Mini-Cog: receiver operating characteristics with expert and naive raters. Int J Geriatr Psychiatry 2001;16:216-222.